XML 70 R53.htm IDEA: XBRL DOCUMENT v3.25.0.1
Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]      
Sales $ 1,517,557 $ 1,533,599 $ 1,945,640
Revenue from Contract with Customer | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk percentage 100.00% 100.00% 100.00%
Revenue from Contract with Customer | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk percentage 100.00% 100.00% 100.00%
United States      
Disaggregation of Revenue [Line Items]      
Sales $ 1,304,971 $ 1,250,094 $ 1,622,537
United States | Revenue from Contract with Customer | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk percentage 86.00% 82.00% 83.00%
International      
Disaggregation of Revenue [Line Items]      
Sales $ 212,586 $ 283,505 $ 323,103
International | Revenue from Contract with Customer | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk percentage 14.00% 18.00% 17.00%
Nylon      
Disaggregation of Revenue [Line Items]      
Sales $ 348,501 $ 356,632 $ 485,241
Nylon | Revenue from Contract with Customer | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk percentage 23.00% 23.00% 25.00%
Caprolactam      
Disaggregation of Revenue [Line Items]      
Sales $ 276,303 $ 298,375 $ 319,863
Caprolactam | Revenue from Contract with Customer | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk percentage 18.00% 20.00% 16.00%
Plant Nutrients      
Disaggregation of Revenue [Line Items]      
Sales $ 458,152 $ 477,929 $ 657,984
Plant Nutrients | Revenue from Contract with Customer | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk percentage 30.00% 31.00% 34.00%
Chemical Intermediates      
Disaggregation of Revenue [Line Items]      
Sales $ 434,601 $ 400,663 $ 482,552
Chemical Intermediates | Revenue from Contract with Customer | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk percentage 29.00% 26.00% 25.00%